Navigation Links
Cimzia® (certolizumab pegol) Data Showed Broad and Rapid Relief From Burden of Symptoms In Rheumatoid Arthritis Patients
Date:5/10/2011

ment due to adverse reactions in the controlled clinical studies was 5% for certolizumab pegol and 2.5% for placebo.

Please see full prescribing information at www.cimzia.com before prescribing.

About CIMZIA®

Cimzia® is the only PEGylated anti-TNF (Tumor Necrosis Factor). Cimzia® has a high affinity for human TNF-alpha, selectively neutralizing the pathophysiological effects of TNF-alpha. Over the past decade, TNF-alpha has emerged as a major target of basic research and clinical investigation. This cytokine plays a key role in mediating pathological inflammation, and excess TNF-alpha production has been directly implicated in a wide variety of diseases. The U.S. Food and Drug Administration (FDA) has approved Cimzia® for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy and for the treatment of adults with moderately to severely active rheumatoid arthritis. Cimzia® in combination with MTX, is approved in the EU for the treatment of moderate to severe active RA in adult patients inadequately responsive to disease-modifying antirheumatic drugs (DMARDs) including MTX. Cimzia® can be given as monotherapy in case of intolerance to MTX or when continued treatment with MTX is inappropriate. UCB is also developing Cimzia® in other autoimmune disease indications. Cimzia® is a registered trademark of UCB PHARMA S.A.

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a biopharmaceutical company dedicated to the research, development and commercialization of innovative medicines with a focus on the fields of central nervous system and immunology disorders. Employing more than 9000 people in over 40 countries, UCB produced r
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
2. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
3. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
4. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
5. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
6. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
7. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
8. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
9. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
10. New Subanalyses of the RE-LY Trial Showed Pradaxa Reduced Stroke Risk in Patients With Varying CHA2DS2-VASc Scores and Types of Non-Valvular Atrial Fibrillation
11. Prolia® (denosumab) Open-Label Extension Trial Showed Continued Increase in Bone Mineral Density Over Five Years of Treatment With Similar Safety Profile Observed in Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
(Date:9/19/2014)... -- 4WEB Medical announces the formal launch of the ... on the market today at this weekend,s American ... Chicago .  The Osteotomy Truss System is a ... 74 size options included in one versatile set. Previously ... to 18 implant sizes, which limited a surgeon,s ability ...
(Date:9/19/2014)... 19, 2014 Merck (NYSE: MRK ), known ... Canada , is teaming with celebrity chef and ... Tus Metas , an educational program encouraging Hispanics with type 2 ... key treatment goal to help reduce the risk of serious health ... at a higher risk for developing type 2 diabetes than non-Hispanic ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... May 30, 2012 The use of an armband-based ... of four approaches to weight loss examined by researchers ... American College of Sports Medicine,s 59th Annual Meeting ... this week in San Francisco. The study, "An Economic ...
... -- Global Information Inc is pleased to ... research reports from Greystone Research Associates examining the ... Sprays. (Photo: http://photos.prnewswire.com/prnh/20120530/CG15754 ) ... Greystone Research Associates, new market study " ...
Cached Medicine Technology:Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 2Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 3New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets 2New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets 3
(Date:9/20/2014)... Lifeinsurancequoteterm.net has released a new blog post explaining the ... provides for vulnerable family members. , Providing financial ... priority for every provider. It is now possible to ... visiting a doctor. , Life insurance plans that ... to $300,000, but only to healthy applicants. Clients who ...
(Date:9/20/2014)... 20, 2014 New PharmaPoint Drug ... Analysis to 2023?. The asthma market saw very ... has become saturated with relatively efficacious standard therapies, ... inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and leukotriene ... competition. However, the launch of seven novel targeted ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against ... Dentistry is re-visiting that advice and changing his stance ... and wine have on oral health. “There’s good news and ... may be beneficial in protecting against gum disease, and red ... on coffee was from the September 2014 issue of ...
(Date:9/20/2014)... Wisconsin (PRWEB) September 20, 2014 QueenBeeTickets.com ... the young star’s tour performances. She will visit many ... of February until the 16th of April. , ... Grande Honeymoon Tour tickets at QueenBeeTickets.com. , The star’s ... opportunity to see their favorite young singer in a ...
(Date:9/20/2014)... “Motherhood is a wonderful gift and a huge ... latest article , “We know that you want to care ... we want to do as well.” , The article explains ... from their Family Physicians who practice obstetrics while pregnant, during ... , To learn more about Community Health Center of Snohomish ...
Breaking Medicine News(10 mins):Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2
... Healthcare Services, Inc. (NYSE: AHS ) today announced operating results for the first quarter 2009, which were in line with management,s expectations. ... Q1 2009 ... $250 million $294 million ... $24 million (29%), Adjusted Diluted EPS* ...
... May 7 The following is a statement from ... of the American Public Health Association:"The American Public Health ... the investments in health included in President Obama,s FY ... care reserve fund which will be used to finance ...
... Highlights- Upgraded by Fitch to BBB- Upgraded by Moody,s ... Balance Sheet Remains Strong With Modest Capital Commitments Through ... Dividend of $0.44 per Share - ... Calif., May 7 Nationwide Health Properties, Inc. (NYSE: ...
... May 7 Minutes after Elizabeth Edwards was presented with ... at the podium to look at her notes as a ... wide smile brightened her face as the audience of 1,600 ... energy and optimism that was reinforced by Edwards, remarks.Edwards received ...
... strain that obesity places on our nation,s health care system ... today released new data from Dr. Kenneth Thorpe ... on Congress to make important tax changes to encourage employees ... part of the briefing, Dr. J. Brent Pawlecki of ...
... Integral Consulting Inc., a national science and engineering ... technology, and sustainability, today announced several promotions within ... and senior level scientists who have contributed to ... President and Principal Sediment Scientist, said the appointments ...
Cached Medicine News:Health News:AMN Healthcare Announces First Quarter 2009 Results 2Health News:AMN Healthcare Announces First Quarter 2009 Results 3Health News:AMN Healthcare Announces First Quarter 2009 Results 4Health News:AMN Healthcare Announces First Quarter 2009 Results 5Health News:AMN Healthcare Announces First Quarter 2009 Results 6Health News:AMN Healthcare Announces First Quarter 2009 Results 7Health News:AMN Healthcare Announces First Quarter 2009 Results 8Health News:AMN Healthcare Announces First Quarter 2009 Results 9Health News:AMN Healthcare Announces First Quarter 2009 Results 10Health News:AMN Healthcare Announces First Quarter 2009 Results 11Health News:AMN Healthcare Announces First Quarter 2009 Results 12Health News:AMN Healthcare Announces First Quarter 2009 Results 13Health News:AMN Healthcare Announces First Quarter 2009 Results 14Health News:AMN Healthcare Announces First Quarter 2009 Results 15Health News:AMN Healthcare Announces First Quarter 2009 Results 16Health News:APHA Applauds Health Reform Fund and Other Health Investments in Budget 2Health News:NHP Reports 2009 First Quarter Results 2Health News:NHP Reports 2009 First Quarter Results 3Health News:NHP Reports 2009 First Quarter Results 4Health News:NHP Reports 2009 First Quarter Results 5Health News:NHP Reports 2009 First Quarter Results 6Health News:NHP Reports 2009 First Quarter Results 7Health News:NHP Reports 2009 First Quarter Results 8Health News:NHP Reports 2009 First Quarter Results 9Health News:NHP Reports 2009 First Quarter Results 10Health News:NHP Reports 2009 First Quarter Results 11Health News:NHP Reports 2009 First Quarter Results 12Health News:NHP Reports 2009 First Quarter Results 13Health News:NHP Reports 2009 First Quarter Results 14Health News:NHP Reports 2009 First Quarter Results 15Health News:NHP Reports 2009 First Quarter Results 16Health News:Elizabeth Edwards Presented With Person of the Year Award by National Hospice and Palliative Care Organization at National Conference 2Health News:With Obesity Key Driver of Rising Health Care Costs, National Business Group on Health Urges Tax Code Changes 2Health News:With Obesity Key Driver of Rising Health Care Costs, National Business Group on Health Urges Tax Code Changes 3Health News:With Obesity Key Driver of Rising Health Care Costs, National Business Group on Health Urges Tax Code Changes 4
... The 201 DM systems bring modern Data ... by means of a wide range of ... be made to prompt the operator for ... required information during analysis. This data can ...
... Glucose 201+ is the latest addition to the ... versions, the new system combines the precision and ... turn around time and ease of use. The ... QC results, together with date and time for ...
... BD ColorPAC Toxin A C. difficile Rapid ... in as little as 10 minutes. When it ... wait. For any laboratory that performs only a ... suspected C. difficile samples for testing, ColorPAC Toxin ...
Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces....
Medicine Products: